阵发性交感神经兴奋综合征患者高压氧疗程与氯硝西泮减药的相关性:回顾性队列研究

Correlation Between Hyperbaric Oxygen Therapy Course and Reduction of Clonazepam in Patients with Paroxysmal Sympathetic Hyperactivity: A Retrospective Cohort Study

  • 摘要: 目的 分析严重脑损伤后阵发性交感神经兴奋综合征( Paroxysmal sympathetic hyperactivity,PSH)患者高压氧(hyperbaric oxygen,HBO)疗程与口服药物氯硝西泮减药的相关性。方法 回顾性纳入2017年9月-2023年7月首都医科大学附属复兴医院康复中心收治的严重脑损伤后PSH患者。收集患者的一般人口社会学资料、病因、病变部位、合并症、入院时查体(生命体征、肌张力、关节活动度)、PSH发作特征、HBO治疗次数、PSH治疗药物及剂量等病历资料。采用多因素Logistic回归法和秩相关分析氯硝西泮减药与HBO治疗次数的相关性。结果 共入选符合纳入和排除标准的PSH患者75例,其中HBO短疗程(治疗10次) 32例(42.7%),氯硝西泮减药38例(50.7%)。HBO长疗程(治疗>10次)患者氯硝西泮减药率高于HBO短疗程患者65.1%(28/43)比31.3%(10/32),P<0.05。多因素Logistic回归分析校正气管切开、心率、关节活动度、发作时出汗、发作时肌张力升高等混杂因素后显示,HBO长疗程与氯硝西泮减药显著相关(OR=0.27,95%CI: 0.09~0.82,P<0.05)。将75例PSH患者按HBO疗程分为以下三组,其中HBO10次组32例(42.7%),HBO20次组15例(20.0%),HBO30次组28例(37.3%)。将氯硝西泮减药与HBO治疗次数进行秩相关分析表明氯硝西泮减药与HBO治疗次数正相关,相关系数为0.331,P=0.004。结论 HBO治疗可减少PSH口服药物氯硝西泮的使用剂量,从而减少药物所致的副作用,可成为PSH的一种非药物治疗方案。

     

    Abstract: Objective Analyze the correlation between the duration of hyperbaric oxygen (HBO) treatment and the reduction of oral medication clonazepam in patients with paroxysmal sympathetic hyperactivity (PSH) after severe brain injury. Method Retrospective inclusion of PSH patients with severe brain injury admitted to the Rehabilitation Center of Fuxing Hospital Affiliated to Capital Medical University from September 2017 to July 2023. Collect general demographic and sociological data, etiology, lesion site, comorbidities, physical examination upon admission (vital signs, muscle tone, joint range of motion), PSH attack characteristics, HBO treatment frequency, PSH treatment drugs and dosage, and other medical records of patients. Multiple logistic regression and rank correlation analysis were used to investigate the correlation between the reduction of clonazepam and the number of HBO treatments. Result A total of 75 PSH patients who met the inclusion and exclusion criteria were selected, including 32 cases (42.7%) of HBO short course (10 treatments) and 38 cases (50.7%) of clonazepam reduction. The reduction rate of clonazepam in patients with long-term HBO treatment (>10 treatments) was higher than that in patients with shortterm HBO treatment (65.1% (28/43) compared to 31.3% (10/32), P<0.05). After adjusting for confounding factors such as tracheostomy, heart rate, joint range of motion, sweating during attacks, and increased muscle tension during attacks, multivariate logistic regression analysis showed a significant correlation (OR=0.27, 95% CI: 0.09-0.82, P<0.05) between long-term HBO treatment and reduction of clonazepam. 75 PSH patients were divided into three groups according to the HBO treatment course, including 32 cases (42.7%) in the HBO 10 dose group, 15 cases (20.0%) in the HBO 20 dose group, and 28 cases (37.3%) in the HBO 30 dose group. The rank correlation analysis between the reduction of chloramphenicol and the number of HBO treatments showed a positive correlation with a correlation coefficient of 0.331 and P=0.004. Conclusion HBO treatment can reduce the dosage of the oral drug clonazepam for PSH, thereby reducing drug-induced side effects and becoming a non pharmacological treatment option for PSH.

     

/

返回文章
返回